Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALUE: MultiHance vs Magnevist in MRA
NCT01260636Phase 3Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadobenate dimeglumine in carotid artery disease, renal artery stenosis (RAS), peripheral artery disease (PAD), aortic disease, sponsored by Bracco Diagnostics Inc.. Started Sep 2009; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
carotid artery diseaserenal artery stenosis (RAS)peripheral artery disease (PAD)aortic disease
Beyond the preview
Go deeper on NCT01260636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260636.